Chengdu Xingcheng Group Visits Chase Sun Pharma for Guidance and Inspection

Chengdu, China – 03 July 2024: Recently, a delegation from Chengdu Xingcheng Group, led by Chen Dayong, Deputy Secretary of the Party Committee, Vice Chairman, and General Manager, along with Zeng Qiang, Deputy General Manager, Chief Compliance Officer, and Chief Legal Counsel, visited Chase Sun Pharma for an inspection and guidance session. They were warmly received by Wu Wenyuan, Chairman of Chase Sun Pharma, Vice Chairman and President Lan Wujun, and Party Secretary and Vice President Li Chunxu, accompanied by the senior management team.

During the visit to the Tianjin Hong Ri Kang Rentang Traditional Chinese Medicine (TCM) Formula Granules Intelligent Production Base, the delegation gained comprehensive insights into the entire production process of TCM formula granules, from processing, extraction, and concentration to formulation. Chen Dayong praised the company's stringent quality control in using authentic medicinal materials and traditional processing methods. He emphasized that quality is the lifeline of pharmaceutical companies and that establishing a full-process quality traceability system is fundamental to the standardization of TCM. Chen urged the company to adhere strictly to national regulations, ensure meticulous quality work, and fulfill the social responsibility of state-owned enterprises.

At the Xuebijing Injection production workshop, the leaders thoroughly understood the production process, quality control system, and market conditions of Xuebijing. They expressed appreciation for the efforts and achievements made by Chase Sun Pharma in the evidence-based research of Xuebijing over the years. Chen Dayong encouraged the R&D and production teams to fully utilize digital methods to conduct research on the mechanisms of Xuebijing, improve quality control capabilities on the production line, and produce reliable medicines that set an example for TCM's global outreach.

During the visit to the ChoiceMMed medical device production base, the leaders spent significant time at the SMT production line of the finger clip pulse oximeter. They inquired in detail about the product's performance, market feedback, and future development plans. The professional capabilities of ChoiceMMed in the research, production, and service of medical devices received high praise from the delegation.